Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management - a retrospective cohort study in Switzerland
- PMID: 31168877
- PMCID: PMC7159768
- DOI: 10.1111/apa.14891
Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management - a retrospective cohort study in Switzerland
Abstract
Aim: To evaluate the frequency of Mycoplasma pneumoniae in nasopharyngeal specimens from children with respiratory tract infections (RTIs) and to detail clinical characteristics and management.
Methods: The study was designed as a retrospective cohort study. All children with RTI and nucleic acid amplification testing from nasopharyngeal specimens were analysed. Clinical data were extracted from electronic health records for all M. pneumoniae-positive cases. Stored samples of cases and a random selection of matched controls were retested using a M. pneumoniae-specific nucleic acid amplification test.
Results: Of 4460 children, 70 (1.6%) were positive for M. pneumoniae with a median age of 6.4 (IQR: 2.7-9.7). M. pneumoniae was the only organism identified in 50/64 (78%) cases. Macrolide treatment was prescribed in 52/65 (80%); prescription was empirical in 29/52 (56%) and targeted in 23/52 (44%) with no difference regarding patient age, oxygen requirement or duration of hospitalisation.
Conclusion: The prevalence of M. pneumoniae in nasopharyngeal specimens of children with RTI was low. The detection of M. pneumoniae influenced antibiotic prescriptions, but the benefit of early empirical versus targeted treatment remains unclear.
Keywords: Bronchitis; LRTI; Macrolides; Pneumonia; x-ray.
©2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Conflict of interest statement
JAB declares that her husband is employed by Novartis. All other authors have nothing to declare.
Figures
References
-
- Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community‐acquired pneumonia in hospitalized children. Pediatrics 2004; 113: 701–7. - PubMed
-
- Meyer Sauteur PM, Van Rossum AMC, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis 2014; 27: 220–7. - PubMed
-
- Moynihan KM, Barlow A, Nourse C, Heney C, Schlebusch S, Schlapbach LJ. Severe Mycoplasma pneumoniae infection in children admitted to pediatric intensive care. Pediatr Infect Dis J 2018; 37: e336–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
